Get all your news in one place.
100's of premium titles.
One app.
Start reading
Caixin Global
Caixin Global
Business
Bao Zhiming and Han Wei

Fosun’s Hospital Unit Secures $41 Million Funding With IPO Promise

What’s new: Shanghai Fosun Pharmaceutical Co. Ltd. (600196.SH) said its hospital business unit has secured 300 million yuan ($41.4 million) in fresh funding from a government-backed investor, a step toward a plan to spin off the unit for a separate listing.

Shanghai Fosun Health Technology Group Co. Ltd., a unit of the Shanghai, Hong Kong-listed drugmaker, sold 2.86% of its equity stake to an investment company controlled by the Chancheng district government of Foshan city. The transaction valued the company at 10.2 billion yuan, Fosun Pharma said in a filing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.